(Total Views: 128)
Posted On: 07/17/2023 11:05:46 AM
Post# of 15445
$HALO News Article - Positive Topline Data Reported from argenx's ADHERE Study of VYVGART Hytrulo with Halozyme's ENHANZE Drug Delivery Technology in Patients with Chronic Inflammatory Demyelinating Polyneuropathy https://marketwirenews.com/news-releases/posi...40067.html
(0)
(0)
My Twitter: WhyteStocks
